headerhome

Opening New Frontiers By Advancing The Promise of PI Signaling Pathways

Thong Q. Le

Select a team to find out more

Thong Q. Le

Thong Q. Le

Chief Executive Officer, Accelerator Corp.

Thong Le joined Accelerator Corp. as its chief executive officer in 2013.  He has spent the past 20 years identifying, funding, managing, and successfully exiting numerous seed- and early-stage investments.  Thong is positioned to grow and expand the Accelerator’s investment model. He serves as Chief Executive Officer and Director of Acylin Therapeutics and all Accelerator IV portfolio companies, which includes Lodo Therapeutics and Petra Pharma. Thong also serves as a director of AgTech Accelerator, an investment vehicle focused on the development of next-generation agriculture companies.

Previously, Thong served as a managing director at WRF Capital, the venture capital investment arm of Washington Research Foundation.  During a 13-year tenure at WRF Capital, Thong played a significant role in the early sourcing, financing, and development of numerous start-up companies, including Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), Corus Pharma, Inc. (acquired by Gilead Sciences), Halosource (LSE: HALO.L), Hyperion Therapeutics, Inc. (Nasdaq: HPTX), Lumera Corp. (NasdaqNM: LMRA), Performant, Inc. (acquired by Mercury Interactive), Pathway Medical Technologies (acquired by MEDRAD) and VLST Corp. (asset acquisition by major international pharmaceutical company).  Thong also led WRF Capital’s investments in Accelerator Corp., AnswerDash, ARZEDA Corp., Cardeas Pharma Corp., Resolve Therapeutics, LLC and Uptake Medical.  He was actively involved in establishing each of these companies as a founding or early investor.

Thong founded MiniMeals, Inc., serving from 1998 to 2000 as President and Chief Executive Officer.  He is a former consultant for Capital Management Consulting and also held positions at Raymond James & Associates, Singer & Xenos Investment Management Company and Capital Management Group LLC, a private investment firm specializing in biomedical ventures.

Thong completed post-graduate studies at the Templeton College at Oxford University after earning a B.A. in government from Harvard University.  He currently serves on the executive boards of the Evergreen Venture Capital Association (EVCA), Life Science Washington, and the Washington Global Health Fund. Thong  was named one of the “40 Under 40” by the Puget Sound Business Journal.

timelinearrowleft